Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status
- PMID: 25441251
- PMCID: PMC6800063
- DOI: 10.1016/j.metabol.2014.09.005
Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status
Abstract
Objective: Soy has been associated with lower risk of cardiovascular disease in Asian countries which consume daily soy. Our study examined whether production of equol, an estrogen metabolite, affected the ability of soy nuts to improve cardiovascular risk factors.
Materials/methods: Sixty postmenopausal women participated in a randomized, controlled, crossover trial of a Therapeutic Lifestyle Changes (TLC) diet alone and a TLC diet in which 0.5 cup of soy nuts (25 g of soy protein and 101 mg of aglycone isoflavones) replaced 25 g of nonsoy protein daily. Each diet was followed for 8 weeks at the end of which blood pressure (BP), lipid levels, adhesion molecules and inflammatory markers were measured.
Results: Women with MetS had significantly higher baseline body mass index (BMI), BP, triglycerides (TG), and soluble intercellular adhesion molecule (sICAM) than women without MetS. In women with MetS on the soy diet, significant reductions in diastolic BP (7.7%; P=0.02), TG (22.9%; P=0.02), C-reactive protein (CRP) (21.4%; P=0.01) and sICAM (7.3%; P=0.03) were noted among equol producers compared to levels on the TLC diet. No significant changes were noted in equol nonproducers. Similarly, in women without MetS, only equol producers had significant reductions in diastolic BP (3.3%, P=0.02) and CRP (30%, P=0.04). In contrast to women with MetS, TG and sICAM levels were not affected in women without MetS, a finding possibly related to lower baseline levels.
Conclusions: Cardiovascular risk reduction with soy nuts is not uniform and may be greater among producers of equol.
Trial registration: ClinicalTrials.gov NCT01740076.
Keywords: Blood pressure; Equol; Isoflavones; Metabolic syndrome; Soy protein.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
There are no conflicts of interest with any of the authors.
Figures


References
-
- American Heart Association. Heart Disease and Stroke Statistics—2005 Update. Dallas, Tx: American Heart Association; 2005.
-
- Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801–11. - PubMed
-
- Welty FK. Alternative hormone replacement regimens: Is there a need for further clinical trials? Curr Opin Lipidol. 2003;14:585–91. - PubMed
-
- Ho S, Woo J, Leung S, Sham A, Lam T, Janus E. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J Nutr. 2000;130:2590–3. - PubMed
-
- Yang G, Shu XO, Jin R, Zhang X, Li HL, Li Q, Gao YT, Zheng W. Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr. 2005;81:1012–17. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous